VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
45 hedge funds and large institutions have $42.9M invested in Viracta Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 40 → 45 (+5)
Holders
45
Holding in Top 10
1
Calls
$1.18M
Puts
$424K
Top Buyers
| 1 | +$4.1M | |
| 2 | +$3.62M | |
| 3 | +$2.4M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$1.9M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$1.81M |
Top Sellers
| 1 | -$583K | |
| 2 | -$97K | |
| 3 | -$76K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$72K |
| 5 |
NFG
Noven Financial Group
Denver,
Colorado
|
-$23K |